Home LiteratureArticle Details
PMID: 16861631 Published · ppublish English Journal Article Research Support, N.I.H., Extramural Research Support, N.I.H., Intramural Research Support, Non-U.S. Gov't

Construction and characterization of an attenuated purine auxotroph in a Francisella tularensis live vaccine strain.

Infection and immunity ·Vol. 74 ·No. 8 ·2006-08-00 ·Pages 4452-61

Pechous R, Celli J, Penoske R, Hayes SF, Frank DW, Zahrt TC

Abstract

Francisella tularensis is a facultative intracellular pathogen and is the etiological agent of tularemia. It is capable of escaping from the phagosome, replicating to high numbers in the cytosol, and inducing apoptosis in macrophages of a variety of hosts. F. tularensis has received significant attention recently due to its potential use as a bioweapon. Currently, there is no licensed vaccine against F. tularensis, although a partially protective live vaccine strain (LVS) that is attenuated in humans but remains fully virulent for mice was previously developed. An F. tularensis LVS mutant deleted in the purMCD purine biosynthetic locus was constructed and partially characterized by using an allelic exchange strategy. The F. tularensis LVS delta purMCD mutant was auxotrophic for purines when grown in defined medium and exhibited significant attenuation in virulence when assayed in murine macrophages in vitro or in BALB/c mice. Growth and virulence defects were complemented by the addition of the purine precursor hypoxanthine or by introduction of purMCDN in trans. The F. tularensis LVS delta purMCD mutant escaped from the phagosome but failed to replicate in the cytosol or induce apoptotic and cytopathic responses in infected cells. Importantly, mice vaccinated with a low dose of the F. tularensis LVS delta purMCD mutant were fully protected against subsequent lethal challenge with the LVS parental strain. Collectively, these results suggest that F. tularensis mutants deleted in the purMCD biosynthetic locus exhibit characteristics that may warrant further investigation of their use as potential live vaccine candidates.

MeSH Terms
Animals Bacterial Proteins/genetics,metabolism Bacterial Vaccines/administration & dosage,immunology Cells, Cultured Culture Media Female Francisella tularensis/genetics,growth & development,immunology,pathogenicity Humans Macrophages/microbiology Mice Mice, Inbred BALB C Mutation Purines/biosynthesis Tularemia/immunology,microbiology,prevention & control Vaccines, Attenuated/administration & dosage,immunology Virulence
Chemicals
Bacterial Proteins Bacterial Vaccines Culture Media Purines Vaccines, Attenuated purine
Authors & Affiliations
6 authors, click to expand affiliations / ORCID
Pechous Roger
Department of Microbiology and Molecular Genetics, Medical College of Wisconsin, 8701 Watertown Plank Road, Milwaukee, WI 53226, USA.
Celli Jean
Penoske Renee
Hayes Stanley F
Frank Dara W
Zahrt Thomas C
References (33)
33 references, click to expand
  1. Genetic approaches to study of biofilms.
    Methods Enzymol. 1999;310:91-109 PMID: 10547784
  2. Tularemia vaccine: past, present and future.
    Antonie Van Leeuwenhoek. 2005 May;87(4):277-81 PMID: 15928980
  3. Francisella tularensis induces cytopathogenicity and apoptosis in murine macrophages via a mechanism that requires intracellular bacterial multiplication.
    Infect Immun. 2001 Jul;69(7):4691-4 PMID: 11402018
  4. Construction, genotypic and phenotypic characterization, and immunogenicity of attenuated DeltaguaBA Salmonella enterica serovar Typhi strain CVD 915.
    Infect Immun. 2001 Aug;69(8):4734-41 PMID: 11447145
  5. Mycobacterium tuberculosis signal transduction system required for persistent infections.
    Proc Natl Acad Sci U S A. 2001 Oct 23;98(22):12706-11 PMID: 11675502
  6. Tularaemia.
    Eur Respir J. 2003 Feb;21(2):361-73 PMID: 12608453
  7. A method for allelic replacement in Francisella tularensis.
    FEMS Microbiol Lett. 2003 May 28;222(2):273-80 PMID: 12770718
  8. Delineation of the molecular mechanisms of Francisella tularensis-induced apoptosis in murine macrophages.
    Infect Immun. 2003 Aug;71(8):4642-6 PMID: 12874344
  9. An attenuated strain of the facultative intracellular bacterium Francisella tularensis can escape the phagosome of monocytic cells.
    Infect Immun. 2003 Oct;71(10):5940-50 PMID: 14500514
  10. Aerogenic immunization of man with live Tularemia vaccine.
    Bacteriol Rev. 1966 Sep;30(3):532-8 PMID: 5917334
  11. Immunization against tularemia: analysis of the effectiveness of live Francisella tularensis vaccine in prevention of laboratory-acquired tularemia.
    J Infect Dis. 1977 Jan;135(1):55-60 PMID: 833449
  12. Salmonella typhi 205aTy, a strain with two attenuating auxotrophic characters, for use in laboratory teaching.
    Infect Immun. 1987 Apr;55(4):892-8 PMID: 3493975
  13. Characterization of aromatic- and purine-dependent Salmonella typhimurium: attention, persistence, and ability to induce protective immunity in BALB/c mice.
    Infect Immun. 1988 Feb;56(2):419-23 PMID: 3276625
  14. Structural and functional analysis of poly(ADP ribose) polymerase: an immunological study.
    Biochim Biophys Acta. 1988 Jul 13;950(2):147-60 PMID: 2454668
  15. Effect of different purine auxotrophic mutations on mouse-virulence of a Vi-positive strain of Salmonella dublin and of two strains of Salmonella typhimurium.
    Microb Pathog. 1987 Aug;3(2):129-41 PMID: 2849016
  16. Effect of a purA mutation on efficacy of Salmonella live-vaccine vectors.
    Infect Immun. 1989 Jun;57(6):1858-61 PMID: 2722244
  17. Live vaccine strain of Francisella tularensis: infection and immunity in mice.
    Infect Immun. 1991 Sep;59(9):2922-8 PMID: 1879918
  18. Intracellular replication is essential for the virulence of Salmonella typhimurium.
    Proc Natl Acad Sci U S A. 1991 Dec 15;88(24):11470-4 PMID: 1763061
  19. Specific proteolytic cleavage of poly(ADP-ribose) polymerase: an early marker of chemotherapy-induced apoptosis.
    Cancer Res. 1993 Sep 1;53(17):3976-85 PMID: 8358726
  20. The tularaemia vaccine.
    J Chem Technol Biotechnol. 1994 Apr;59(4):315-20 PMID: 7764815
  21. Deletion of purE attenuates Brucella melitensis infection in mice.
    Infect Immun. 1996 Jun;64(6):2188-92 PMID: 8675325
  22. Tularemia pneumonia.
    Semin Respir Infect. 1997 Mar;12(1):61-7 PMID: 9097380
  23. Initiation of biofilm formation in Pseudomonas fluorescens WCS365 proceeds via multiple, convergent signalling pathways: a genetic analysis.
    Mol Microbiol. 1998 May;28(3):449-61 PMID: 9632250
  24. Persistence and protective efficacy of a Mycobacterium tuberculosis auxotroph vaccine.
    Infect Immun. 1999 Jun;67(6):2867-73 PMID: 10338493
  25. Prophylactic effectiveness of live and killed tularemia vaccines. I. Production of vaccine and evaluation in the white mouse and guinea pig.
    J Immunol. 1961 Oct;87:415-25 PMID: 13889609
  26. EVALUATION OF LIVE TULAREMIA VACCINE PREPARED IN A CHEMICALLY DEFINED MEDIUM.
    Appl Microbiol. 1965 Mar;13:232-5 PMID: 14325885
  27. Construction and characterization of a highly efficient Francisella shuttle plasmid.
    Appl Environ Microbiol. 2004 Dec;70(12):7511-9 PMID: 15574954
  28. The complete genome sequence of Francisella tularensis, the causative agent of tularemia.
    Nat Genet. 2005 Feb;37(2):153-9 PMID: 15640799
  29. Vaccination strategies for Francisella tularensis.
    Adv Drug Deliv Rev. 2005 Jun 17;57(9):1403-14 PMID: 15919131
  30. In vivo Himar1-based transposon mutagenesis of Francisella tularensis.
    Appl Environ Microbiol. 2006 Mar;72(3):1878-85 PMID: 16517634
  31. Adenosine inhibits tumor necrosis factor-alpha release from mouse peritoneal macrophages via A2A and A2B but not the A3 adenosine receptor.
    J Pharmacol Exp Ther. 2006 Apr;317(1):172-80 PMID: 16339914
  32. Efficacy of the live attenuated Francisella tularensis vaccine (LVS) in a murine model of disease.
    Vaccine. 2005 Apr 8;23(20):2680-6 PMID: 15780452
  33. Sequencing of the Francisella tularensis strain Schu 4 genome reveals the shikimate and purine metabolic pathways, targets for the construction of a rationally attenuated auxotrophic vaccine.
    Microb Comp Genomics. 2000;5(1):25-39 PMID: 11011763
Article Info
Journal
Infection and immunity
Abbr.
Infect Immun
ISSN
0019-9567
Published
2006-08-00
Pages
4452-61
Language
English
Region
United States
NLM ID
0246127
PMCID
PMC1539594
Subset
IM
Grants
NIAID NIH HHS · U54 AI057153 · United States
NIAID NIH HHS · U54-AI-057153 · United States
Intramural NIH HHS · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com